Fibre4
Natural health product licensed in Canada
- Other names
- Guar Seed Fibre, SunFiber, The Right Fibre4, The Right Fibre4 IBS Intestinal Discomfort
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80138717
- Status
- Active licence
- Licence date
- 24 February 2025
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, NA, Glycolate d'amidon sodique, Acide stéarique, Crospovidone, Glycérine, Cellulose, Hydroxypropylcellulose, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants, adolescents et adultes | minimum: 8 years | 5 Comprimé | 1 Tous les jours |
| Enfants, adolescents et adultes | minimum: 8 years | 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fibre. Source of fibre for the maintenance of healthy gastrointestinal functions. Helps (to) improve intestinal regularity including constipation and/or diarrhea. Helps (to) improve bowel regularity in people with Irritable Bowel Syndrome/IBS. Helps (to) relieve constipation and mild gastrointestinal discomfort in people with Irritable Bowel Syndrome/IBS. Helps (to) reduce the frequency of bowel irregularity and minor gastrointestinal symptoms associated with Irritable Bowel Syndrome/IBS including flatulence, bloating, dyspepsia and altered bowel habits. Helps (to) relieve bowel irregularity, bloating, dyspepsia and other minor gastrointestinal symptoms in people with Irritable Bowel Syndrome/IBS. Helps (to) improve intestinal regularity in children. Helps modulate stool conditions (from either loose or hard) to normal conditions. Helps reduce the need for laxative use. Helps reduce incidents of diarrhea. Helps reduce glycemic response and glycemic index when taken with food.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80138717
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.